Summary We previously detected elevated transforming growth factor beta-1 (TGF-11) serum levels in patients with invasive bladder carcinomas. In this study, we therefore investigated whether elevated serum levels correlate with enhanced TGF-1 expression in human bladder tumours. mRNA levels of TGF-p1, -12 and -133 were reduced in bladder tumour tissue to 86%, 68% and 56%, respectively, of the levels in normal urothelium. On the other hand, TGF-1l protein levels were found to be higher in superficial tumours (T7-T,) (mean level of 0.153 ng mg-1) and in invasive TJ/3 tumours (mean level of 0.104 ng mg-') compared with normal urothelium (mean level of 0.065 ng mg-').
Transforming growth factors-1 (TGF-P) are a family of multifunctional homodimeric polypeptides. Three different isoforms of TGF-,B have been found in mammalian cells, termed and -133. The mature 25-kDa peptides of all isoforms are structurally and functionally similar (Roberts and Sporn, 1990) , although their regulation of secretion is distinct. TGF-,B1 is secreted from most cells as a 225-kDa latent complex. It is assumed that TGF-P2 and -P3 are also synthesized as latent forms; however, detailed knowledge about the structures of these complexes is lacking (Brown et al, 1990) . Activation of latent TGF-1 by acidification or, more likely, by certain proteases, like plasmin or cathepsin, play a critical role in the bioavailability of TGF-,B (Lyons et al, 1988) .
TGF-1 was regarded as a negative growth regulator because of its potent anti-proliferative effects on many cell types, such as endothelial and epithelial cells and various cell types of haematopoietic origin in vitro (Roberts and Sporn, 1990) . In contrast, overexpression of TGF-P1 has been described in several tumours in vivo (Gorsch et al, 1992; Thompson et al, 1992; Steiner et al, 1994) and has also been associated with tumour progression and metastasis (Weidner et al, 1991; Gajdusek et al, 1993) . The advantageous effect of this increased TGF-1 synthesis on tumour growth is probably caused by autocrine or paracrine activities resulting in increased cell matrix interactions, inhibited immune surveillance or increased angiogenic activity (Kekow et al, 1990; Yang and Moses, 1990; Kehrl, 1991) . It has been suggested that in most cases malignant epithelial cell lines have lost their responsiveness to the inhibiting activity of TGF-1 (Chang et al, 1993) .
In the course of investigations about the role of TGF-1 as a potential tumour-promoting factor, elevated TGF-1 I plasma levels have been detected in patients with invasive prostate cancer (Ivanovic et al, 1995) . In a similar study, we previously found significantly elevated TGF-,B1 serum levels in patients with invasive bladder carcinomas (Eder et al, 1996) . In the present study, we investigated whether those elevated TGF-1 serum levels correlate with increased TGF-,B expression in bladder tumour tissue and whether isoforms differ in their respective expression. In addition, we cultured primary epithelial and fibroblast urothelial cells in order to study the importance of the stromal part in TGF-f expression and secretion.
MATERIALS AND METHODS
Acid-ethanol extraction of TGF-,1l from bladder tissue We investigated tissue specimens from 23 patients with transitional cell carcinoma (TCC) and compared them with a group of 22 samples from normal bladder urothelium. Tumour specimens comprised nine superficial (Ta, Cis, TI) and 14 invasive tumours (T2-T4). Normal bladder urothelium was dissected from histologically proven non-malignant areas during radical cystectomy. Tumour samples were taken either during transurethral resection or during radical cystectomy. All samples were immediately frozen in liquid nitrogen. The extraction procedure as described by Roberts et al (1983) Primers were synthesized on a 381A DNA Synthesizer (Applied Biosystems, Vienna, Austria): glyceraldehyde-3 phosphate dehydrogenase (GAPDH) was used as an internal control: 5'-CACCACCATGGAGAAGGCTGG-3' (GAPDH 365) and 5'-GTCTAGCTCAGGGATGACCTTG-3' (GAPDH 735as*); TGF-f 1: 5'-AAGTGGATCC ACGAGCCCAA-3' (TGF-0 1) and 5'-GCTGCACTTGCAGGAGCGCAC-3' (TGF-plas*); TGF-P2: 5'-AAATGGATACACGAACCCCAA-3' (TGF-,2) and 5'-GCTGCATTTGCAAGACTTTAC-3' (TGF-,2as*); TGF-13: 5'-AAGTGGGTCCATGAACCTAA-3' (TGF-33) and 5'-GCTA-CATTTACAAGACTTCAC-3' (TGF-,3as*). Antisense primers were fluorescence labelled at the 5' end as indicated by an asterisk. Synthesis was performed on a thermocycler 60 (Bio med) with 20 s at 94'C, 15 s at 96°C, 1 min at 55°C and 30 s at 73°C (34 cycles).
Afterwards, TGF-[B (1 pl) and GAPDH (1 gl) samples were mixed with 2.5 pl of formamide and denatured at 90°C for 2 min. DNA fragments were separated electrophoretically in a 6% polyacrylamide gel using the 370A DNA Sequencer (Applied Biosystems). Fluorescence was measured and quantitated using 672A Software 1.2 (Applied Biosystems). Amounts of TGF-P mRNA were normalized against the corresponding amounts of GAPDH mRNA, which is unaffected by TGF-,1 (Edwards et al, 1985; Norgaard et al, 1996) . Results are presented as TGF-, -GAPDH ratio. All measurements were performed at least twice.
Culture of primary bladder cells Primary culture
Primary cell cultures were established from fresh tissue specimens taken at transurethral resection or radical cystectomy. The tissue was minced into little pieces. The obtained tissue pieces were British Journal of Cancer (1997) 
Culture of epithelial cells
For the culture of epithelial cells, we used a serum-free MCDB-153 medium (Sigma) supplemented with 1% of a solution of nonessential amino acids (Biological Industries), epidermal growth factor (EGF; 5 ng ml-'); Life Technologies, Gibco), bovine pituitary extracts (30 jig ml-'; Life Technologies, Gibco), 0.2% bovine serum albumin (Behring, Vienna, Austria), transferrin (10 jg ml-'), insulin (1 jig ml-') and penicillin/streptomycin (120 IU ml-', 120 jg ml-'). Figure IA Culture of fibroblast cells Fibroblasts were cultured in EMEM supplemented with 10% FCS, a 1% solution of non-essential amino acids (Biological Industries) and penicillin/streptomycin (120 IU ml-', 120 jig ml-'). Collection of cell pellets and culture supernatants Cells were harvested with trypsin/EDTA (0.05%, 0.01%), centrifuged at 8000 r.p.m. for 5 min and shock frozen in liquid nitrogen. Cell culture supermatants were taken from 72 h conditioned media, centrifuged to remove cell debris and stored at -20°C. The amount of TGF-4 was corrected by the number of cells. Values are presented in ng 10-cells. In order to avoid falsepositive results, TGF-. content of unconditioned media was subtracted from the values measured in cell-conditioned media. We used standard media as described above. EMEM that was used for cultivation of fibroblasts contained 1.3 ng ml-TGF-1 and 0.06 pg ml-' TGF-P2, whereas the serum-free MCDB-153, used for cultivation of epithelial cells, contained only 0.06 ng ml' TGF-B1 and 0.01 pg ml-' TGF-,2.
Enzyme-linked immunosorbent assay (ELISA) TGF-f1 and TGF-132 ELISAs (Genzyme and R&D Systems respectively) were performed according to the manufacturer's instructions. Since only active forms of TGF-P1 and -42 can be recognized by the antibodies used in the kits, all samples except those received by acid-ethanol extraction were activated by acidification as described previously (Eder et al, 1996) . Figure 2 . In normal urothelium, all three TGF-ps were expressed.
Statistical analysis
TGF-I1 mRNA was also present in all 16 tumour samples. On the contrary, TGF-,2 mRNA was only found in 11 and TGF-, Figure 3 , TGF-f1 protein levels were significantly higher in superficial tumours (Ta9 TI) with 0.153 ng mg-' (n = 9) than in normal urothelium, which contained only 0.065 ng mg-' (n = 22) (P = 0.01). Similarly, invasive T2-T3
tumours had increased TGF-P 1 protein levels of 0.104 ng mg-' (n = 11). However, the difference to normal controls and superficial tumours failed to reach statistical significance. Invasive T4 tumours contained significantly lower TGF-P1 protein levels of 0.02 ng mg-' (n = 3) than superficial (P = 0.03) and invasive T/T3 tumours (P = 0.01) respectively. TGF-,1 levels of T4 tumours were also reduced compared with normal urothelium, but differences were not statistically significant (P = 0.15).
TGF-01 protein levels were higher in G1/G2 tumours (n = 8) than in poorly differentiated G3 tumours (n = 15) (0.140 ng mg-' and 0.098 ng mg-' respectively) (data not shown). Differences were not statistically significant.
Correlation of TGF-,1 levels between serum and tissue specimens in individual patients
We investigated whether there is a correlation between preoperative serum TGF-f1 levels and the amount of TGF-f1 in tumour tissue samples from the same patient. However, we could not find any correlation (r = 0.09) (Figure 4) . Tumour-derived fibroblasts (n = 7) expressed higher TGF-[3 mRNA levels (TGF-13 -GAPDH ratio = 0.021) than epithelial cells. By contrast, TGF-[1 and TGF-,B2 mRNA levels were almost equal in epithelial cells and fibroblasts. Tumour-derived fibroblasts contained a median TGF-[1 -GAPDH ratio of 0.569 (n = 7) and a median TGF-P2 -GAPDH ratio of 0.028 (n = 7). Figure 6 .
Epithelial cells (BCE) derived from invasive tumours (T2 -T4, n = 4) secreted slightly higher TGF-f1 levels of 4.23 ng 10-i cells than epithelial cells derived from superficial tumours (Ta-TI, n = 7) (3.79 ng TGF-j1 10-5 cells). However, there was no significant difference from normal epithelial cells (BNE), whose conditioned media contained 3.74 ng TGF-[1 10-cells (n = 7).
Compared with epithelial cells, 0.75 ngTGF-[3 10-5 cells and 0.74 ngTGF-[Bl 105 cells were detected in supematants of normal (BNF, n = 7) and tumour-derived fibroblasts (BCF, n = 10) respectively.
Epithelial cells derived from superficial (n = 3) and invasive (n = 2) tumours secreted higher amounts of TGF-[B2 (0.8 ng 10-5 cells) than normal epithelial cells (n = 2) in whose supernatants no TGF-[2 was present. Only very low amounts of 0.08 ng TGF-[B2 10-5cells (n = 4) were found in supernatants from tumour-derived fibroblasts. Amounts of TGF-1I in cell culture supernatants were generally higher than those of TGF-[B2.
DISCUSSION
Overexpression of TGF-[B1 has been commonly associated with prostate (Thompson et al, 1992) , breast and renal cancer (Gomella et al. 1989 , Coombes et al, 1990 . In a previous study, we therefore determined TGF-1I in sera from bladder cancer patients. TGF-[1 was found to be significantly elevated in sera from patients with invasive bladder cancer (T2-T4) compared with serum levels from patients with superficial tumours (Ta-T,) and normal control subjects (Eder et al, 1996) .
In this study, we were interested in whether elevated TGF-[ serum levels correlate with increased TGF-[ expression in bladder tumours. However, we found reduced expression of mRNA of all three TGF- [ isoforms,  in bladder tumour samples compared with normal urothelium. There was neither a correlation of TGF-[ mRNA expression with tumour stages (Ta-T4) nor with tumour grades (G1-G3). These results were somehow unexpected, considering the increased serum levels in bladder cancer patients. On the other hand, reduced TGF-[1 mRNA has already been demonstrated in high-grade human bladder tumours (Coombs et al, 1993; Miyamoto et al, 1995) .
Investigating In the tissue samples we investigated, there was also no correlation between mRNA and protein levels. This finding is in accordance with previous studies, which already indicated that there is no evidence for a direct correlation between TGF-i1 protein and mRNA levels. Similar discrepancies have already been described in the mouse embryo (Pelton et al, 1991) . Differential expression seems to be caused by post-transcriptional regulation of expression through a 5' untranslated sequence in the TGF-0 mRNA (Kehrl et al, 1986; Kim et al, 1992) . On the basis of our results, we conclude that neither mRNA nor protein levels found in tumour tissue provide a conclusive explanation for increased TGF-11 levels in the serum of patients with invasive bladder cancer.
An important question is whether the stromal part of the tumour plays an important role in TGF-P production. It is well established that the TGF-fs are secreted proteins; thus, certain cells may synthesize and release TGF-P into the extracellular matrix of adjacent cells that have the potential to respond. Both autocrine and paracrine factors, which are produced by epithelial and stromal cells, may play an important role in the local growth control, since it is known that epithelium loses its growth capacity when separated from the stroma (Kooistra et al, 1995) . Some malignant tumours may use TGF-f released from their environment for enhancing their invasiveness and metastatic behaviour, while at the same time being resistant to the growth-suppressive effect of TGF-0. Exposure of tumour cells to exogenous TGF-f has been
shown to stimulate tumour cell invasion in vivo and metastatic potential in vitro (Welch et al, 1990) . In order to investigate the contribution of different cell types to protein levels in the tissue, we cultured human primary bladder cells separating epithelial from fibroblast cells by different culture conditions. Our measurements in samples of cultured primary cells revealed remarkable differences among the TGF-P isoforms concerning their expression and secretion. TGF-P1 mRNA was expressed in lower levels in tumour-derived compared with normal epithelial cells, whereas TGF-u1 protein secretion into the culture medium was almost equal between these two cell types. On the other hand, 
